Newsfeeds - Spark Newswire

1 minute read

Earnings

A Preview Of Eledon Pharmaceuticals’s Earnings

Today, 2:02 PM

Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that Eledon Pharmaceuticals will report an earnings per share (EPS) of $-0.83.

ELDN

3 minute read

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings

By Shanthi Rexaline

Today, 2:02 PM

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.

APLT

32 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 2:02 PM

On Monday, 524 stocks hit new 52-week lows.

AAL

1 minute read

‘2 “Strong Buy” Penny Stocks That Could See Outsized Gains’ TipRanks Article Highlighting Maronne Bio, Eledon Pharma

By Benzinga Newsdesk

Today, 2:02 PM

https://www.tipranks.com/news/article/2-strong-buy-penny-stocks-that-could-see-outsized-gains-3/

ELDN

6 minute read

70 Biggest Movers From Friday

By Lisa Levin

Today, 2:02 PM

Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.

ABSI

3 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 2:02 PM

ABSI

10 minute read

Earnings Scheduled For November 11, 2021

By Benzinga Insights

Today, 2:02 PM

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.

ACHR

2 minute read

CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement

By Benzinga Newsdesk

Today, 2:02 PM

CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and

CDNA

1 minute read

Events
News

Eledon Pharmaceuticals Announces Presentation On AT-1501 At The Virtual 2021 Northeast Amyotrophic Lateral Sclerosis Consortium

By Benzinga Newsdesk

Today, 2:02 PM

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ:ELDN), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or

ELDN

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 2:02 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO